Diabetes Care, Vol 18, Issue 7 1013-1016, Copyright © 1995 by American Diabetes Association

ARTICLES

Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM

JC Chan, CK Cheung, MY Cheung, R Swaminathan, JA Critchley and CS Cockram
Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories.

OBJECTIVE--Microalbuminuria predicts mortality in non-insulin-dependent diabetes mellitus (NIDDM), but its association with deterioration of renal function remains more controversial than in insulin-dependent diabetes mellitus (IDDM). Using albumin-to-creatinine ratios (ACRs) in random spot urine samples is a convenient method for evaluating albuminuria. We studied prospectively the predictive values of albuminuria in NIDDM when assessed by this urine measurement. RESEARCH DESIGN AND METHODS--Between 1991 and 1992, we restudied the clinical and biochemical status of 403 Chinese NIDDM patients recruited in 1989 after a follow-up period of 26.6 +/- 3.2 months (mean +/- SD). Spot urine ACR was measured on two occasions and microalbuminuria was defined as a mean ACR between 5.6 and 38 mg/mmol. RESULTS--From the original cohort, 29 patients had died mostly because of cardiovascular events with or without renal failure. The overall relative risk of death in patients with abnormal albuminuria was 7.1 (P < 0.001) (microalbuminuria: 3.7, P = 0.04; macroalbuminuria: 11, P < 0.001). On multivariate analysis, the independent predictive factors for mortality were plasma creatinine (wald = 12.1, P < 0.001) and glucose concentrations (wald = 10.4, P < 0.001) in the normo- and microalbuminuric patients (n = 11) and age (wald = 4.4, P = 0.03) and plasma creatinine (wald = 8.2, P < 0.01) in the macroalbuminuric group (n = 18). In the survivors (n = 374), baseline spot urine ACR was independently associated with 2-year spot urine ACR in the normo- (P < 0.001), micro- (P < 0.01), and macroalbuminuric groups (P = 0.01). In addition, baseline spot urine ACR was independently related to 2-year plasma creatinine (P = 0.01) in the macroalbuminuric group. The rates of change of the reciprocal of plasma creatinine ( delta [Cr]-1) were -27.3 +/- 62.5, -43.4 +/- 68.6, and -108.8 +/- 98.81.mumol01.month-1 in the normo-, micro-, and macroalbuminuric groups, respectively (P < 0.001). The delta [Cr]-1 was independently and inversely related to the baseline spot urine ACR (P < 0.001) and 2-year systolic blood pressure (P < 0.001). CONCLUSIONS--Abnormal albuminuria as indicated by a random spot urine ACR > 5.6 mg/mmol predicts increased mortality and is associated with the progression of albuminuria and deterioration of renal function in Chinese NIDDM patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. Cosson, I. Pham, P. Valensi, J. Paries, J.-R. Attali, and A. Nitenberg Impaired Coronary Endothelium-Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary Arteries Diabetes Care, January 1, 2006; 29(1): 107 - 112. [Abstract] [Full Text] [PDF]

				M. Cusick, A. D. Meleth, E. Agron, M. R. Fisher, G. F. Reed, G. L. Knatterud, F. B. Barton, M. D. Davis, F. L. Ferris III, E. Y. Chew, et al. Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27 Diabetes Care, March 1, 2005; 28(3): 617 - 625. [Abstract] [Full Text] [PDF]

				W. Y. S. Leung, W.-Y. So, P. C. Y. Tong, M. K. W. Lo, K.-F. Lee, G. T. C. Ko, W.-B. Chan, C. S. Cockram, B. M. Brenner, S. Shahinfar, et al. The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2519 - 2525. [Abstract] [Full Text] [PDF]

				J. C.N. Chan, N. M.S. Wat, W.-Y. So, K. S.L. Lam, C.-T. Chua, K.-S. Wong, Z. Morad, T. Z. Dickson, D. Hille, Z. Zhang, et al. Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: An Asian perspective from the RENAAL study Diabetes Care, April 1, 2004; 27(4): 874 - 879. [Abstract] [Full Text] [PDF]

				M. L. Wheeler, S. E. Fineberg, N. S. Fineberg, R. G. Gibson, and L. L. Hackward Animal Versus Plant Protein Meals in Individuals With Type 2 Diabetes and Microalbuminuria: Effects on renal, glycemic, and lipid parameters Diabetes Care, August 1, 2002; 25(8): 1277 - 1282. [Abstract] [Full Text] [PDF]

				C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. K. Klein The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus Arch Intern Med, April 24, 2000; 160(8): 1093 - 1100. [Abstract] [Full Text] [PDF]

				W.B. CHAN, J.C.N. CHAN, C.C. CHOW, V.T.F. YEUNG, W.Y. SO, J.K.Y. LI, G.T.C. KO, R.C.W. MA, and C.S. COCKRAM Glycaemic control in type 2 diabetes: the impact of body weight, {beta}-cell function and patient education QJM, March 1, 2000; 93(3): 183 - 190. [Abstract] [Full Text] [PDF]